CSACI position statement: epinephrine auto-injectors and children < 15 kg. - Wikidata - awgldk - TriplyDB

CSACI position statement: epinephrine auto-injectors and children < 15 kg.

CSACI position statement: epinephrine auto-injectors and children < 15 kg.

http://www.wikidata.org/entity/Q34483043

about

Autoinjectors Preferred for Intramuscular Epinephrine in Anaphylaxis and Allergic Reactions.Anaphylaxis in children Self-medication of anaphylactic reactions due to Hymenoptera stings-an EAACI Task Force Consensus Statement.

P2860

Q37404527-CC4E36BD-D818-4C4E-B359-E969257B8F80 Q41344985-8716EEE6-D591-4BD1-BAB3-FEF1672D46A6 Q51533907-51A5D161-05B7-4428-9D07-98BEE69CE9EC

P2860

CSACI position statement: epinephrine auto-injectors and children < 15 kg.

http://www.wikidata.org/entity/Q34483043

description

2015 nî lūn-bûn

@nan

2015 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

CSACI position statement: epinephrine auto-injectors and children < 15 kg.

@ast

CSACI position statement: epinephrine auto-injectors and children < 15 kg.

@en

CSACI position statement: epinephrine auto-injectors and children < 15 kg.

@nl

type

label

CSACI position statement: epinephrine auto-injectors and children < 15 kg.

@ast

CSACI position statement: epinephrine auto-injectors and children < 15 kg.

@en

CSACI position statement: epinephrine auto-injectors and children < 15 kg.

@nl

prefLabel

CSACI position statement: epinephrine auto-injectors and children < 15 kg.

@ast

CSACI position statement: epinephrine auto-injectors and children < 15 kg.

@en

CSACI position statement: epinephrine auto-injectors and children < 15 kg.

@nl

P1433

Q34483043-F9D20754-7126-4612-9234-480D4FA584A9

P1476

Q34483043-9DD3A914-985F-4E25-AE45-900D9E375FC6

P2093

Q34483043-0600DABD-E55B-4B29-BCC8-28CC71A3EF17

Q34483043-8C78CB4D-B46E-412C-A321-B48B21BB991D

Q34483043-A4657FDB-4F49-4F2E-A486-F569BCD516AE

Q34483043-B0CB7CBF-D6B6-4F6F-AA0C-2FCF21C82346

Q34483043-BE29C1EB-382A-49A2-A191-C419A432F8E5

P2860

Q34483043-125F97DC-6CF3-40D3-88C6-2355A14D9813

Q34483043-296EEFB6-182F-445E-BA07-4EB7F50EF20F

Q34483043-2C39A3E9-6B78-49D7-8D68-5D181957BA5E

Q34483043-3485F56F-A258-4D4F-938B-51D4A5073B6B

Q34483043-3AD0BA42-E144-4F7B-8793-B434AA897148

Q34483043-5114E007-2412-48D9-9E24-516C11F5A5B5

Q34483043-5C2D6DE1-D857-4C60-A006-8E6F9796A5FF

Q34483043-692D2BF9-06DD-49F3-A664-F66CF028DB76

Q34483043-6CA13BB7-D745-4147-8AB7-1D43CA50AD67

Q34483043-ABBEE8D1-94A3-49F8-B166-8E60CB643B3E

P2888

Q34483043-B9CE48F8-E557-4822-979C-434351589045

P304

Q34483043-D1B639E2-941A-45CE-A843-E2F420AA51AE

P31

Q34483043-20D695E6-238B-434B-9E63-B1C09256BFEC

P356

Q34483043-4B369456-58F8-4BB5-9EDD-973F9F92C878

P433

Q34483043-E0DA5099-F4A3-4759-A700-177552F65805

P478

Q34483043-43B31CBC-BEA5-4E42-BD3C-0F56A86A6986

P577

Q34483043-8F1533F2-F365-4DE1-AA36-4DA27B94351D

P5875

Q34483043-60803E4A-7AB0-4ED3-8715-33536B381670

P6179

Q34483043-33331991-CF18-43D3-BBD1-F296C8F96E2B

P698

Q34483043-FB90725C-0AB2-4495-BAB1-E14D05999B45

P932

Q34483043-2361C840-F7A7-4270-B15C-0BB50134DB0A

P356

S13223-015-0086-9

P1433

Allergy, Asthma & Clinical Immunology

P1476

CSACI position statement: epinephrine auto-injectors and children < 15 kg.

@en

P2093

Douglas P Mack

http://www.w3.org/2001/XMLSchema#string

Harold Kim

http://www.w3.org/2001/XMLSchema#string

Michelle Halbrich

http://www.w3.org/2001/XMLSchema#string

Stuart Carr

http://www.w3.org/2001/XMLSchema#string

Wade Watson

http://www.w3.org/2001/XMLSchema#string

P2860

Adrenaline for the treatment of anaphylaxis: cochrane systematic review.

Children under 15 kg with food allergy may be at risk of having epinephrine auto-injectors administered into bone

Anaphylaxis: A review and update.

Fatal and near-fatal anaphylactic reactions to food in children and adolescents.

Self-injectable epinephrine for first-aid management of anaphylaxis.

Emergency treatment of anaphylaxis in infants and children.

Anaphylaxis fatalities and admissions in Australia.

How dangerous is food allergy in childhood? The incidence of severe and fatal allergic reactions across the UK and Ireland.

First-aid treatment of anaphylaxis to food: focus on epinephrine.

Anaphylaxis in infants: can recognition and management be improved?

P2888

s13223-015-0086-9

P304

20

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S13223-015-0086-9

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P577

2015-06-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

279232169

http://www.w3.org/2001/XMLSchema#string

P6179

1043999364

http://www.w3.org/2001/XMLSchema#string

P698

26131015

http://www.w3.org/2001/XMLSchema#string

P932

4485331

http://www.w3.org/2001/XMLSchema#string